Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples